Frontiers | Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity
Immune optimization inspired artificial natural killer cell earthquake prediction method | SpringerLink
NKp30 ‐ A prospective target for new cancer immunotherapy strategies - Pinheiro - 2020 - British Journal of Pharmacology - Wiley Online Library
MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4 | PLOS ONE
MGAT5 knockout increases NKG2DL expression and activates NKG2D in... | Download Scientific Diagram
Paired NK cell receptors controlling NK cytotoxicity - ScienceDirect
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis: Immunology Today
In vivo Mg 2+ supplementation of XMEN patient restored NKG2D expression... | Download Scientific Diagram
Frontiers | Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Cancers | Free Full-Text | Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
Molecular mechanisms that regulate the cell surface expression of NKG2D... | Download Scientific Diagram
Cancers | Free Full-Text | Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
NK cells of mice phagocytose hMSCs - Dong - 2013 - Hepatology - Wiley Online Library
Cancers | Free Full-Text | Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
The Role of Activating and Inhibitory NK Cell Receptors in Antitumor Immune Response | IntechOpen
Natural killer cell immunotypes related to COVID-19 disease severity | Science Immunology
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
Cancers | Free Full-Text | Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
Killer activation receptor - Wikipedia
MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4 | PLOS ONE
Directing CAR NK Cells via the Metabolic Incorporation of CAR Ligands into Malignant Cell Glycans | ACS Chemical Biology
New Perspectives to Improve the MHC-I Unrestricted Immune Mechanisms against Malignant Tumors
PDF) Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors
Natural killer cell immunotypes related to COVID-19 disease severity | Science Immunology
Generating universal chimeric antigen receptor expressing cell products from induced pluripotent stem cells: beyond the autologous CAR-T cells | Chinese Medical Journal
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway - Document - Gale OneFile: Health and Medicine
